Acumen Pharmaceuticals
ABOS
ABOS
60 hedge funds and large institutions have $158M invested in Acumen Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
2.94% more ownership
Funds ownership: 68.55% → 71.48% (+2.9%)
43% less capital invested
Capital invested by funds: $278M → $158M (-$120M)
Holders
60
Holding in Top 10
3
Calls
$534K
Puts
$211K
Top Buyers
| 1 | +$2.99M | |
| 2 | +$1.3M | |
| 3 | +$1.05M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$935K |
| 5 |
Two Sigma Investments
New York
|
+$475K |
Top Sellers
| 1 | -$3.25M | |
| 2 | -$2.13M | |
| 3 | -$2.09M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.53M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.34M |